UConn is one of the Universities participating at the worldwide CSL Research Acceleration Initiative opportunity. CSL, a Top 25 Biotech Companies of 2022, is interested in fast-tracking discovery of innovative biotherapies in the therapeutic areas of Immunology, Hematology, Respiratory, Cardiovascular & Metabolic, Transplant, and Vaccines.
Successful applicants will receive up to $400k over 2 years. Researchers who wish to apply are required to submit a non-confidential, 300 word online abstract by February 23, 2023. You can find link here: https://inova.partneringplace.com/OppPortal/portal/csl/. Please contact Ana Fidantsef, Industry Liaison at the TCS office, ana.fidantsef@uconn.edu, if you are interested in applying.
Additionally, interested researchers are invited to join an online information session to learn more: Monday, February 6, 4pm ET. Please contact Ana if you would like to attend.
For more information, contact: Ana Fidantsef at ana.fidantsef@uconn.edu